saikosaponin d has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, M; Huang, N; Li, X; Liu, J; Qi, X; Sun, R; Zhang, X | 1 |
| Fan, M; Huang, N; Li, X; Liu, J; Qi, X; Sun, R | 1 |
2 other study(ies) available for saikosaponin d and Neutropenia
| Article | Year |
|---|---|
Saikosaponin d contributed to cancer chemotherapy induced neutropenia therapy by promoting neutrophil differentiation via activation CBL-dependent ERK pathway.
Topics: Animals; Antineoplastic Agents; Blood Bactericidal Activity; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Immunologic Factors; Infection Control; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neutropenia; Neutrophils; Oleanolic Acid; Oncogene Protein v-cbl; Saponins | 2020 |
Saikosaponin a contributed to CCIN treatment by promoting neutrophil bactericidal activity via activation CBL-dependent ERK pathway.
Topics: Blotting, Western; Cell Differentiation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Neutropenia; Neutrophils; Oleanolic Acid; Proto-Oncogene Proteins c-cbl; Saponins | 2021 |